Arix Bioscience PLC (GB:ARIX)

Arix Bioscience (ARIX) Financial Statements


Arix Bioscience Financial Overview

Arix Bioscience's market cap is currently ―. The company's EPS TTM is p0.12; its P/E ratio is 12.62; Arix Bioscience is scheduled to report earnings on April 23, 2024, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Dec 21Jun 21Dec 20Jun 20
Income Statement-
Total Revenue-----
Gross Profit-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments£ 131.09M£ 134.23M£ 163.79M£ 174.36M£ 43.99M
Total Assets£ 228.87M£ 257.08M£ 283.52M£ 330.71M£ 252.72M
Total Debt£ 94.00K£ 121.00K£ 148.00K£ 268.00K£ 647.00K
Net Debt£ -131.00M£ -134.11M£ -163.65M£ -174.09M£ -43.35M
Total Liabilities£ 1.21M£ 1.72M£ 2.34M£ 2.50M£ 1.69M
Stockholders Equity£ 227.67M£ 255.36M£ 281.19M£ 328.21M£ 251.02M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in GBP

Arix Bioscience Earnings and Revenue History

Arix Bioscience Debt to Assets

Arix Bioscience Cash Flow

Arix Bioscience Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis